NEW DELHI: The Hyderabad-based Covid vaccine production firm Bharat Biotech submitted information in the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government resources.
“We’ve obtained the information in the phase III trials,” a senior administration official .
Bharat Biotech’s Covaxin is among the 3 vaccines that are being used in India.
The stage III information of its own vaccine have been contested various occasions and that’s what gets the information necessary that will determine the effectiveness of this vaccine.
The business has produced the vaccine in conjunction with the Indian Council of Medical Research (ICMR).
In a media briefing a couple of days back by the Union Health Ministry, Dr V K Paul, who’s a part (Health) Niti Aayog and also the mind of this Covid job force of the nation, stated that the firm will be submitting the information contained in seven to eight weeks.
Bharat Biotech has Filed Covaxin’s Phase III trial Information into DCGI: Govt Resources
